Alpha 2.0
Login Register
» Authors » Antonios Keramopoulos

Antonios Keramopoulos

Explore the profile of Antonios Keramopoulos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 156
Followers 0
Related Specialties
Oncology
Pathology
Anatomy & Histology
Top 10 Co-Authors
Ioanna Giannopoulou
Lydia Nakopoulou
Paraskevi Alexandrou
Eleni Mylona
Sofia Markaki
Sophia Katsarou
Ioanna Tsirmpa
Nikos Pandis
Effie G Panayotopoulou
George Liapis
Published In
Mod Pathol
BMC Cancer
Breast Cancer Res
Breast Cancer Res Treat
Pathol Oncol Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Germline mutations in a clinic-based series of pregnancy associated breast cancer patients
Zografos E, Korakiti A, Andrikopoulou A, Rellias I, Dimitrakakis C, Marinopoulos S, et al.
BMC Cancer . 2021 May; 21(1):572. PMID: 34011307
Background: Pregnancy-associated breast cancer (PABC) defined as breast cancer diagnosed during gestation, lactation or within 1 year after delivery, represents a truly challenging situation with significantly increasing incidence rate. The...
2.
Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients
Giaginis C, Sampani A, Kotta-Loizou I, Giannopoulou I, Danas E, Politi E, et al.
Pathol Oncol Res . 2017 Aug; 24(3):631-640. PMID: 28808873
Hu-antigen R (HuR), a RNA-binding protein, is considered to play a crucial role in tumor development and progression by stabilizing or regulating a group of cellular mRNAs of cancer-related genes,...
3.
An immunohistochemical evaluation of the proteins Wnt1 and glycogen synthase kinase (GSK)-3β in invasive breast carcinomas
Mylona E, Vamvakaris I, Giannopoulou I, Theohari I, Papadimitriou C, Keramopoulos A, et al.
Histopathology . 2013 Apr; 62(6):899-907. PMID: 23551536
Aims: Our purpose was to investigate, in breast carcinomas, the prognostic importance of the proteins Wnt1 and glycogen synthasekinase (GSK)-3β, and their associations with classic clinicopathological indices. Methods And Results:...
4.
Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis
Nakopoulou L, Panayotopoulou E, Giannopoulou I, Tsirmpa I, Katsarou S, Mylona E, et al.
J Clin Pathol . 2007 Jun; 60(7):808-15. PMID: 17596546
Background: Breast cancer is a genetically complex disease, which involves the accumulation of various structural and numerical chromosomal aberrations. Aim: To assess the numerical status of chromosomes 16 and X...
5.
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Konstantopoulou I, Rampias T, Ladopoulou A, Koutsodontis G, Armaou S, Anagnostopoulos T, et al.
Breast Cancer Res Treat . 2007 Apr; 107(3):431-41. PMID: 17453335
127 Greek breast/ovarian cancer families were screened for germline BRCA1/2 mutations by dHPLC followed by direct sequencing. Our results indicated 16 and 5 breast/ovarian cancer families bearing deleterious mutations in...
6.
Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype
Liapis G, Mylona E, Alexandrou P, Giannopoulou I, Nikolaou I, Markaki S, et al.
APMIS . 2007 Feb; 115(2):104-14. PMID: 17295676
Smad2 participates in the TGF-beta signaling pathway, where it cooperates with transcription factors to regulate expression of defined genes. The purpose of this study was to investigate the expression pattern...
7.
The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma
Mylona E, Alexandrou P, Giannopoulou I, Liapis G, Sofia M, Keramopoulos A, et al.
Gynecol Oncol . 2006 Dec; 104(3):557-63. PMID: 17150246
Objectives: Vascular endothelial growth factors A and B (VEGF-A and VEGF-B) play a major role in angiogenesis and activate VEGF receptor 1 (VEGFR-1). However, the clinicopathologic and clinical value of...
8.
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome
Mylona E, Magkou C, Giannopoulou I, Agrogiannis G, Markaki S, Keramopoulos A, et al.
Breast Cancer Res . 2006 Oct; 8(5):R57. PMID: 17032447
Introduction: Our aim was to study the expression pattern of tissue inhibitor of metalloproteinases (TIMP)-3 protein in invasive breast carcinoma, and its clinicopathological and prognostic value as well as its...
9.
Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer
Georgopoulos N, Adonakis G, Fotopoulos A, Koika V, Spinos N, Saltamavros A, et al.
Gynecol Endocrinol . 2006 May; 22(4):185-9. PMID: 16723304
In postmenopausal women with estrogen receptor (ER)-positive breast cancer, long-term tamoxifen administration has proved beneficial after surgical treatment and subsequent chemotherapy. One of the major adverse effects of tamoxifen is...
10.
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype
Mylona E, Alexandrou P, Giannopoulou I, Rafailidis P, Markaki S, Keramopoulos A, et al.
Cancer Detect Prev . 2006 Apr; 30(2):111-7. PMID: 16632244
Background: Ets-1 is a transcription factor, implicated in the regulation of expression of various genes'. The aim of the present study was to investigate the expression of ets-1 protein in...